Twitter | Pretraživanje | |
Pretraživanje Osvježi
SY Investing 46 min
Odgovor korisniku/ci @syinvesting
Good summary of 's planned spinoff and separation intentions - Dividing into two companies - One R&D-focused company - One consumer health company through JV with (+maybe the prescription derm business) - Cost is £2.4B over 2 years
Reply Retweet Označi sa "sviđa mi se"
André D. Harrell 3 h
Reply Retweet Označi sa "sviđa mi se"
Thomas Jefferson University 6 h
Jefferson Institute for Bioprocessing and  have partnered to create the JIB-BCG Digital Demonstrator for digital innovation in operations. The demonstrator is the first of its kind in the US. Learn more ▶️
Reply Retweet Označi sa "sviđa mi se"
Alliance Pharma 8 h
Here's how you along with the CDC and scientists can prevent the spread of the :
Reply Retweet Označi sa "sviđa mi se"
ClearLight Biotechnologies, LLC 9 h
At ClearLight Biotechnologies we enable modern heroes to see more biology and explore further with Tru3D™. Get Started with CLARITY and Tru3D.
Reply Retweet Označi sa "sviđa mi se"
McKesson Corporation 9 h
By focusing on high touch services that can help enhance patient outcomes, and life sciences companies can overcome the market access challenges faced by orphan drugs. Download our white paper to learn more:
Reply Retweet Označi sa "sviđa mi se"
WWFHTX 9 h
The industry provides 196,000 high-skill, high-wage jobs in Texas. See new video featuring @ TXManufacturers
Reply Retweet Označi sa "sviđa mi se"
yaffagraceco 10 h
Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells:
Reply Retweet Označi sa "sviđa mi se"
Rothwell Figg 10 h
Partner Daniel Shores and other experts discussed the increasingly important field of at a event this morning, including whether to seek or trade secret protection for your invention and the future role of trade secrets in and .
Reply Retweet Označi sa "sviđa mi se"
Ozmosi 10 h
Good news for patients with rare and fatal heart disease....and good news for Pfizer
Reply Retweet Označi sa "sviđa mi se"
Deep Lens 11 h
What if you could increase your visibility with healthcare providers and sponsored sites to accelerate trials to completion?
Reply Retweet Označi sa "sviđa mi se"
L.E.K. Consulting 11 h
How can companies optimize processes to ensure the successful launch of strong products? We explain here:
Reply Retweet Označi sa "sviđa mi se"
Michael Heidorn 13 h
simply explained! Thermo Scientific
Reply Retweet Označi sa "sviđa mi se"
Talent4Boards 13 h
iVeena Delivery Systems appoints Dr Amir Shojaei to
Reply Retweet Označi sa "sviđa mi se"
Neethu Sreenivasan 14 h
Is this Merck being a focused player or a leaner player?
Reply Retweet Označi sa "sviđa mi se"
Elfab Limited 14 h
Could biologics be delivered orally? Recent research suggests some strategies that may make it possible:
Reply Retweet Označi sa "sviđa mi se"
Softbox Systems 15 h
We are a trusted partner to some of the world’s leading & companies, for whom maintaining the cold chain is a matter of patient safety.
Reply Retweet Označi sa "sviđa mi se"
Matt Heberling, PhD 18 h
Ancestral sequence reconstruction gives thermostable candidates as scaffolds for potential therapeutic applications!
Reply Retweet Označi sa "sviđa mi se"
BongeneSearch 4. velj
How this company wants to change how we treat pain:
Reply Retweet Označi sa "sviđa mi se"
Deloitte Health Care 4. velj
What are the key drivers that could help deliver a sustainable future for R&D? Find out in our latest report:
Reply Retweet Označi sa "sviđa mi se"

Povezana pretraživanja

@deloittehealth